Latest Funding News

Koonenberry Gold announces the start of a fully funded air core drilling program at the Junee Copper-Gold Joint Venture Project in NSW, managed by Newmont. The program targets multiple porphyry systems with promising geological analogies to world-class deposits.

North Stawell Minerals has launched its 2025 diamond drilling program targeting significant gold mineralisation at the Wildwood and Darlington prospects in Victoria, backed by a recent $1.3 million capital raise.

5E Advanced Materials has entered a pivotal Restructuring Support Agreement with its primary lenders to equitize $63.5 million in convertible notes and secure up to $30 million in funding. The transaction, subject to shareholder approval, aims to strengthen the balance sheet and advance the company toward its Final Investment Decision.

Greenwing Resources has announced a maiden Mineral Resource Estimate of 1.07 million tonnes Lithium Carbonate Equivalent at its San Jorge Lithium Brine Project in Argentina, with promising geophysical data suggesting significant upside potential.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Fonterra Shareholders' Fund has secured conditional approval to delist from the ASX, aiming to consolidate its trading on the NZX by late February 2025. This move is expected to streamline operations and reduce costs for unitholders.

Sipa Resources has inked agreements to acquire four advanced gold projects in South Australia and Western Australia, positioning itself for a significant exploration boost. The $2.2 million deal, coupled with a $1.75 million capital raise, signals a strategic pivot towards expanding its resource base.

GreenTech Metals has restarted its stage 2 diamond core drilling at the Whundo Cu-Zn project in West Pilbara, backed by a completed $2.3 million placement to fund exploration and resource expansion efforts.

5E Advanced Materials has announced a $30 million funding package alongside a significant restructuring of its convertible notes, aiming to strengthen its balance sheet and advance toward a Final Investment Decision.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Arafura Rare Earths has locked in a A$200 million convertible note investment from the National Reconstruction Fund Corporation, marking a pivotal step toward developing Australia's first ore-to-oxide rare earths processing operation at Nolans.

Ingenia Communities Group has raised its FY25 EBIT and EPS guidance following a robust first half, driven by operational efficiencies and a revitalised development pipeline.